Studies have reported that the PI3K pathway can be activated by signalings other than KRAS [103], and that amplification and the overexpression of the transcriptional coactivator Yap1 can also drive KRAS-independent PDAC tumor maintenance [104]. The gene discussed is KRAS; the disease is neoplasm.